These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25778882)

  • 1. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M; Li X; Wang L; Yue S; Zhao B
    BMC Nephrol; 2022 Apr; 23(1):144. PubMed ID: 35418036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites.
    Holub D; Flodrova P; Pika T; Flodr P; Hajduch M; Dzubak P
    Biomed Res Int; 2019; 2019():3689091. PubMed ID: 30834260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
    Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
    Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
    Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
    Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
    Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
    Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
    Paueksakon P; Fogo AB; Sethi S
    Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
    Vrana JA; Theis JD; Dasari S; Mereuta OM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kurtin PJ; Grogg KL; Dogan A
    Haematologica; 2014 Jul; 99(7):1239-47. PubMed ID: 24747948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report.
    Adachi M; Kitamura M; Muta K; Maekawa A; Uramatsu T; Tadokoro M; Funakoshi S; Hisano S; Kuwahara N; Shimizu A; Mukae H; Nishino T
    BMC Nephrol; 2020 May; 21(1):195. PubMed ID: 32448180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of amyloidosis subtypes based on tissue biopsy site - Consecutive analysis of 729 patients at a single amyloidosis center in Japan.
    Abe R; Katoh N; Takahashi Y; Takasone K; Yoshinaga T; Yazaki M; Kametani F; Sekijima Y
    Pathol Int; 2021 Jan; 71(1):70-79. PubMed ID: 33112446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen alpha amyloidosis: insights from proteomics.
    Chapman J; Dogan A
    Expert Rev Proteomics; 2019 Sep; 16(9):783-793. PubMed ID: 31443619
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis.
    Aoki M; Kang D; Katayama A; Kuwahara N; Nagasaka S; Endo Y; Terasaki M; Kunugi S; Terasaki Y; Shimizu A
    Clin Exp Nephrol; 2018 Aug; 22(4):871-880. PubMed ID: 29372474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.